Showing results (41-50 of 191) with videos related to

Sort By:
Pageof 20
Sarcoma|August 6, 2019
Combination Therapy with Disulfiram, Copper, and Doxorubicin for Osteosarcoma: In Vitro Support for a Novel Drug Repurposing StrategyJonathan B Mandell, Feiqi Lu, Matthew Fisch, et al.
Cancer Chemotherapy and Pharmacology|October 12, 2012
Formation of active products of benzaldehyde dimethane sulfonate (NSC 281612, DMS612) in human blood and plasma and their activity against renal cell carcinoma linesRobert A Parise, Bean N Anyang, Julie L Eiseman, et al.
Cancer Chemotherapy and Pharmacology|November 16, 2014
Plasma pharmacokinetics and tissue and brain distribution of cisplatin in musk shrewsJulie L Eiseman, Jan H Beumer, Lora H Rigatti, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 10, 2021
Development and validation of an LC-MS/MS generic assay platform for small molecule drug bioanalysisRobert A Parise, Joseph M Covey, Melinda G Hollingshead, et al.
Biomedical Chromatography : BMC|May 24, 2024
Quantitation of tazemetostat in human plasma using liquid chromatography-tandem mass spectrometryMarco Orleni, Robert A Parise, Julianne L Holleran, et al.
Cancer Chemotherapy and Pharmacology|January 23, 2022
Dose-dependent bioavailability and tissue distribution of the ATR inhibitor AZD6738 (ceralasertib) in miceBrian F Kiesel, Jianxia Guo, Robert A Parise, et al.
Steroids|January 26, 2023
Murine toxicology and pharmacokinetics of lead next generation galeterone analog, VNPP433-3βElizabeth Thomas, Retheesh S Thankan, Puranik Purushottamachar, et al.
Journal of the National Cancer Institute|February 19, 2011
Chemopreventative potential of the cruciferous vegetable constituent phenethyl isothiocyanate in a mouse model of prostate cancerAnna A Powolny, Ajay Bommareddy, Eun-Ryeong Hahm, et al.
Cancer Chemotherapy and Pharmacology|May 27, 2008
Effect of antacid on imatinib absorptionBrian A Sparano, Merrill J Egorin, Robert A Parise, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
A mass balance and disposition study of the DNA methyltransferase inhibitor zebularine (NSC 309132) and three of its metabolites in miceJan H Beumer, Erin Joseph, Merrill J Egorin, et al.
Pageof 20